Platform Technology Partners
YARW

Platform Technology Partners’s Yarrow Bioscience YARW Stock Holding History

Platform Technology Partners’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16
Closed -$20K – 248
2021
Q3 		$20K Sell
16
-2
-11% -$3.88K 0.01% 234
2021
Q2 		$56K Buy
+18
New +$71.2K 0.02% 249
2020
Q4 		$153K Sell
27
-6
-18% -$37.7K 0.07% 210
2020
Q3 		$198K Buy
+33
New +$193K 0.12% 170

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Platform Technology Partners's YARW Position: Q4 2021 in Review

Platform Technology Partners sold out of Yarrow Bioscience (YARW) in Q4 2021, closing a stake of 16 shares — an estimated $20K sold.

Platform Technology Partners first reported a position in YARW in Q3 2020 and held it in 4 quarters. The position peaked at $198K in Q3 2020. 49 funds tracked by Wall St. Rank hold YARW as of Q4 2021.

  • Platform Technology Partners reported no remaining Yarrow Bioscience position as of Q4 2021 after selling out during the quarter.
  • Platform Technology Partners sold 16 Yarrow Bioscience shares in Q4 2021, an estimated $20K.
  • Platform Technology Partners first reported a position in Yarrow Bioscience in Q3 2020 and held it in 4 quarters.
  • Platform Technology Partners's Yarrow Bioscience position peaked at $198K in Q3 2020.
  • 49 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2021.

Based on Platform Technology Partners's 13F filing for Q4 2021, filed 1 Feb 2022.